"ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment ev" by Shaji Kumar, Zihan Wei et al.
 

ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation

Affiliations

Aurora Cancer Care, Advocate Aurora Health

Presentation Notes

Poster presented at: ASCO Annual Meeting 2021; June 2021; Chicago, IL

Document Type

Abstract

Link to Full Text

 

Plum Print visual indicator of research metrics
PlumX Metrics
  • Usage
    • Abstract Views: 11
see details

Share

COinS